BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 6717863)

  • 1. 17 beta-estradiol for postmenopausal estrogen replacement therapy.
    Nichols KC; Schenkel L; Benson H
    Obstet Gynecol Surv; 1984 Apr; 39(4):230-45. PubMed ID: 6717863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Aerodiol: the efficacy and tolerability of intranasal estrogen administration. An overview].
    Genazzani AR; Cappagli B; Ciaponi M
    Minerva Ginecol; 2003 Jun; 55(3):189-200. PubMed ID: 14581864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 17β-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis.
    Rioux JE; Devlin MC; Gelfand MM; Steinberg WM; Hepburn DS
    Menopause; 2018 Nov; 25(11):1208-1213. PubMed ID: 30358715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, acceptability, and metabolic effects of transdermal estradiol in the management of postmenopausal women.
    Padwick ML; Endacott J; Whitehead MI
    Am J Obstet Gynecol; 1985 Aug; 152(8):1085-91. PubMed ID: 3927737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
    Chakravarti S; Collins WP; Thom MH; Studd JW
    Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen replacement therapy: indications and complications.
    Judd HL; Meldrum DR; Deftos LJ; Henderson BE
    Ann Intern Med; 1983 Feb; 98(2):195-205. PubMed ID: 6824255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative controlled trial of a novel oral estrogen therapy, estradiol acetate, for relief of menopause symptoms.
    Utian WH; Speroff L; Ellman H; Dart C
    Menopause; 2005; 12(6):708-15. PubMed ID: 16278614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17 beta-estradiol: comparison with conventional oral estrogens used for hormone replacement.
    Powers MS; Schenkel L; Darley PE; Good WR; Balestra JC; Place VA
    Am J Obstet Gynecol; 1985 Aug; 152(8):1099-106. PubMed ID: 2992279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous estrogen replacement therapy. Effects on circulating estrogens, gonadotropins and prolactin.
    Holst J; Cajander S; Carlström K; Damber MG; von Schoultz B
    Acta Obstet Gynecol Scand; 1983; 62(1):49-53. PubMed ID: 6858624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations of unconjugated and conjugated estrogens and gonadotrophins following application of various estrogen preparations after oophorectomy and in the menopause.
    Strecker JR; Lauritzen C; Goessens L
    Maturitas; 1979 Feb; 1(3):183-90. PubMed ID: 228157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's.
    Bhavnani BR
    J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):473-82. PubMed ID: 12943738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
    Gambrell RD
    Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints.
    Balfour JA; Heel RC
    Drugs; 1990 Oct; 40(4):561-82. PubMed ID: 2083514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparative study of Estraderm and Premarin in the amelioration of postmenopausal symptoms.
    Place VA; Powers M; Darley PE; Schenkel L; Good WR
    Am J Obstet Gynecol; 1985 Aug; 152(8):1092-9. PubMed ID: 2992278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic studies on low dose estradiol 17 beta administered orally to postmenopausal women.
    Sipinen S; Lähteenmäki P; Luukkainen T
    Acta Obstet Gynecol Scand; 1980; 59(2):149-53. PubMed ID: 6773291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate.
    Furuhjelm M; Carlström K
    Acta Obstet Gynecol Scand; 1977; 56(4):351-61. PubMed ID: 602703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women.
    Mandel FP; Geola FL; Meldrum DR; Lu JH; Eggena P; Sambhi MP; Hershman JM; Judd HL
    J Clin Endocrinol Metab; 1983 Jul; 57(1):133-9. PubMed ID: 6304131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogens for the menopause. Maximizing benefits, minimizing risks.
    Seller JC
    Postgrad Med; 1977 Sep; 62(3):73-9. PubMed ID: 197509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.